Cathay Biotech Inc.

XSSC:688065 Stock Report

Market Cap: CN¥31.1b

Cathay Biotech Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Xiucai Liu

Chief executive officer

CN¥4.1m

Total compensation

CEO salary percentagen/a
CEO tenure6.9yrs
CEO ownershipn/a
Management average tenure6.9yrs
Board average tenure5.4yrs

Recent management updates

Recent updates

CEO

Xiucai Liu (69 yo)

6.9yrs
Tenure
CN¥4,116,900
Compensation

Dr. Xiucai Liu has been Chairman of Cathay Industrial Biotech, Ltd. (formerly known as Cathay Biotech Inc.) since April 2006 and serves as its President. Dr. Liu serves as Chairman and Chief Executive Offi...

Leadership Team

NamePositionTenureCompensationOwnership
Xiucai Liu
Chairman & President6.9yrsCN¥4.12mno data
Huiqing Zang
VP, Secretary of the Board of Directors & Vice Chairman6.9yrsCN¥1.24mno data
Chen Yang
VP, Core Technician4.5yrsCN¥1.20mno data
Yijun Du
Vice President6.9yrsCN¥1.48mno data
Jun Zuo
Vice President5.1yrsCN¥2.71mno data
Hong Guang Zhang
Vice President6.9yrsCN¥1.24mno data
Benliang Hou
Vice President6.9yrsCN¥892.80kno data
Xiao Kun Chen
Accounting Supervisorno datano datano data
6.9yrs
Average Tenure
58yo
Average Age

Experienced Management: 688065's management team is seasoned and experienced (6.9 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Xiucai Liu
Chairman & President6.9yrsCN¥4.12mno data
Huiqing Zang
VP, Secretary of the Board of Directors & Vice Chairman6.9yrsCN¥1.24mno data
Chen Yang
VP, Core Technicianless than a yearCN¥1.20mno data
Wei Dong Deng
Vice Chairman of the Board1.2yrsno datano data
Guohua Zhang
Chairman of the Supervisory Board6.9yrsno datano data
Xiang Yang Wu
Independent Director3.9yrsCN¥120.00kno data
5.4yrs
Average Tenure
56yo
Average Age

Experienced Board: 688065's board of directors are considered experienced (5.4 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/24 01:17
End of Day Share Price 2026/07/24 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Cathay Biotech Inc. is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Junjun ZhuHaitong International Research Limited
Ting Zhou ZhuangHuatai Research